Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Tarsus Pharmaceuticals, Inc.(TARS) | 1,030,277 | 607,689 | -422,588 | $33.89M | $33.65M | 9.61% | -$238.1K |
| Crinetics Pharmaceuticals In | 426,913 | 516,431 | +89,518 | $21.82M | $26.41M | 7.54% | +$4.59M |
| Scholar Rock Holding Corporation(SRRK) | 0 | 357,185 | +357,185 | $0 | $15.44M | 4.41% | +$15.44M |
| Blueprint Medicines Corp | 85,000 | 169,374 | +84,374 | $7.86M | $14.77M | 4.22% | +$6.91M |
| Forte Biosciences Inc | 0 | 609,225 | +609,225 | $0 | $13.84M | 3.95% | +$13.84M |
| Viridian Therapeutics, Inc.(VRDN) | 499,977 | 469,949 | -30,028 | $11.37M | $9.01M | 2.57% | -$2.37M |
| Enliven Therapeutics Inc | 499,566 | 394,538 | -105,028 | $12.76M | $8.88M | 2.53% | -$3.88M |
| TG Therapeutics, Inc.(TGTX) | 0 | 291,240 | +291,240 | $0 | $8.77M | 2.50% | +$8.77M |
| Insmed Incorporated(INSM) | 154,835 | 119,800 | -35,035 | $11.30M | $8.27M | 2.36% | -$3.03M |
| Structure Therapeutics IncADS | 115,200 | 284,085 | +168,885 | $5.06M | $7.70M | 2.20% | +$2.65M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 179,000 | 178,989 | -11 | $9.94M | $7.53M | 2.15% | -$2.41M |
| Catalyst Pharmaceuticals Inc | 417,850 | 349,649 | -68,201 | $8.31M | $7.30M | 2.08% | -$1.01M |
| Avalo Therapeutics, Inc.(AVTX) | 970,359 | 970,259 | -100 | $9.22M | $7.21M | 2.06% | -$2.01M |
| Cytokinetics, Incorporated(CYTK) | 170,147 | 149,982 | -20,165 | $8.98M | $7.06M | 2.01% | -$1.93M |
| Vir Biotechnology, Inc.(VIR) | 0 | 897,862 | +897,862 | $0 | $6.59M | 1.88% | +$6.59M |
| Tectonic Therapeutic, Inc.(TECX) | 267,145 | 142,328 | -124,817 | $8.09M | $6.57M | 1.88% | -$1.52M |
| Spyre Therapeutics, Inc.(SYRE) | 302,247 | 282,159 | -20,088 | $8.89M | $6.57M | 1.88% | -$2.32M |
| BridgeBio Pharma, Inc.(BBIO) | 285,613 | 215,713 | -69,900 | $7.27M | $5.92M | 1.69% | -$1.35M |
| Kodiak Sciences Inc.(KOD) | 476,586 | 576,166 | +99,580 | $1.24M | $5.73M | 1.64% | +$4.49M |
| Arcus Biosciences, Inc.(RCUS) | 744,000 | 378,363 | -365,637 | $11.38M | $5.63M | 1.61% | -$5.74M |
| Bright Minds Biosciences Inc.(DRUG) | 0 | 152,211 | +152,211 | $0 | $5.48M | 1.57% | +$5.48M |
| Eledon Pharmaceuticals, Inc.(ELDN) | 0 | 1,126,637 | +1,126,637 | $0 | $4.64M | 1.33% | +$4.64M |
| Alpha Cognition Inc. Common Stock(ACOG) | 0 | 755,867 | +755,867 | $0 | $4.45M | 1.27% | +$4.45M |
| LENZ Therapeutics, Inc.(LENZ) | 204,513 | 149,502 | -55,011 | $4.86M | $4.32M | 1.23% | -$539.0K |
| Rezolute, Inc.(RZLT) | 887,230 | 857,230 | -30,000 | $4.30M | $4.20M | 1.20% | -$102.6K |
| Sarepta Therapeutics, Inc.(SRPT) | 54,176 | 34,087 | -20,089 | $6.77M | $4.14M | 1.18% | -$2.62M |
| Evolus, Inc.(EOLS) | 258,279 | 373,265 | +114,986 | $4.18M | $4.12M | 1.18% | -$63.3K |
| Mineralys Therapeutics, Inc.(MLYS) | 180,000 | 332,390 | +152,390 | $2.18M | $4.09M | 1.17% | +$1.91M |
| Nuvalent Inc | 52,238 | 52,216 | -22 | $5.34M | $4.09M | 1.17% | -$1.26M |
| Janux Therapeutics, Inc.(JANX) | 0 | 74,691 | +74,691 | $0 | $4.00M | 1.14% | +$4.00M |
| Verona Pharma PlcADS | 0 | 80,000 | +80,000 | $0 | $3.72M | 1.06% | +$3.72M |
| Cybin D/B/A Helus Pharma(HELP) | 367,195 | 397,175 | +29,980 | $3.26M | $3.50M | 1.00% | +$238.7K |
| Arcturus Therapeutics Holdings Inc.(ARCT) | 0 | 200,000 | +200,000 | $0 | $3.39M | 0.97% | +$3.39M |
| Lexeo Therapeutics, Inc.(LXEO) | 257,216 | 499,301 | +242,085 | $2.33M | $3.29M | 0.94% | +$960.2K |
| Abeona Therapeutics Inc.(ABEO) | 583,593 | 533,581 | -50,012 | $3.69M | $2.97M | 0.85% | -$716.3K |
| Relay Therapeutics, Inc.(RLAY) | 693,350 | 693,308 | -42 | $4.91M | $2.86M | 0.82% | -$2.05M |
| Rocket Pharmaceuticals, Inc.(RCKT) | 197,096 | 221,911 | +24,815 | $3.64M | $2.79M | 0.80% | -$850.9K |
| Protagonist Therapeutics Inc | 0 | 70,000 | +70,000 | $0 | $2.70M | 0.77% | +$2.70M |
| Aligos Therapeutics, Inc.(ALGS) | 0 | 64,300 | +64,300 | $0 | $2.56M | 0.73% | +$2.56M |
| Zevra Therapeutics, Inc.(ZVRA) | 0 | 292,772 | +292,772 | $0 | $2.44M | 0.70% | +$2.44M |
| Xenon Pharmaceuticals Inc.(XENE) | 107,187 | 62,052 | -45,135 | $4.22M | $2.43M | 0.69% | -$1.79M |
| Ventyx Biosciences Inc | 192,647 | 1,092,590 | +899,943 | $420.0K | $2.39M | 0.68% | +$1.97M |
| OnKure Therapeutics, Inc.CL A(OKUR) | 0 | 253,754 | +253,754 | $0 | $2.18M | 0.62% | +$2.18M |
| Monte Rosa Therapeutics, Inc.(GLUE) | 311,593 | 311,575 | -18 | $1.65M | $2.16M | 0.62% | +$510.9K |
| Acelyrin Inc | 677,074 | 676,608 | -466 | $3.34M | $2.12M | 0.61% | -$1.21M |
| Cardiff Oncology, Inc.(CRDF) | 0 | 450,000 | +450,000 | $0 | $1.95M | 0.56% | +$1.95M |
| Sangamo Therapeutics, Inc.(SGMOQ) | 0 | 1,860,179 | +1,860,179 | $0 | $1.90M | 0.54% | +$1.90M |
| Nektar Therapeutics(NKTR) | 1,312,405 | 2,029,028 | +716,623 | $1.71M | $1.89M | 0.54% | +$180.9K |
| Protara Therapeutics, Inc.(TARA) | 155,712 | 350,489 | +194,777 | $285.0K | $1.85M | 0.53% | +$1.57M |
| Alector Inc | 0 | 950,000 | +950,000 | $0 | $1.80M | 0.51% | +$1.80M |
| Terns Pharmaceuticals Inc | 308,497 | 308,491 | -6 | $2.57M | $1.71M | 0.49% | -$863.8K |
| Achilles Therapeutics PlcADS | 1,443,181 | 1,441,141 | -2,040 | $1.47M | $1.64M | 0.47% | +$170.9K |
| Immunic, Inc.(IMUX) | 493,496 | 1,614,170 | +1,120,674 | $814.3K | $1.61M | 0.46% | +$799.9K |
| Alto Neuroscience, Inc.(ANRO) | 0 | 350,000 | +350,000 | $0 | $1.48M | 0.42% | +$1.48M |
| iBio, Inc.CON NEW(IBIO) | 600,000 | 599,913 | -87 | $1.33M | $1.47M | 0.42% | +$137.8K |
| Cidara Therapeutics Inc | 0 | 53,940 | +53,940 | $0 | $1.45M | 0.41% | +$1.45M |
| Tourmaline Bio Inc | 108,483 | 67,927 | -40,556 | $2.79M | $1.38M | 0.39% | -$1.41M |
| Springworks Therapeutics Inc | 0 | 37,519 | +37,519 | $0 | $1.36M | 0.39% | +$1.36M |
| Trevi Therapeutics, Inc.(TRVI) | 0 | 325,000 | +325,000 | $0 | $1.34M | 0.38% | +$1.34M |
| Delcath Systems, Inc.(DCTH) | 100,370 | 100,365 | -5 | $906.3K | $1.21M | 0.35% | +$302.1K |
| Jasper Therapeutics, Inc.(JSPR) | 55,175 | 55,107 | -68 | $1.04M | $1.18M | 0.34% | +$140.3K |
| Allakos Inc | 972,675 | 971,950 | -725 | $635.4K | $1.18M | 0.34% | +$540.7K |
| Lexicon Pharmaceuticals, Inc.(LXRX) | 0 | 1,550,000 | +1,550,000 | $0 | $1.14M | 0.33% | +$1.14M |
| Milestone Pharmaceuticals Inc.(MIST) | 466,019 | 466,030 | +11 | $708.3K | $1.10M | 0.31% | +$391.5K |
| Third Harmonic Bio Inc | 0 | 100,000 | +100,000 | $0 | $1.03M | 0.29% | +$1.03M |
| Verve Therapeutics Inc | 170,000 | 169,991 | -9 | $822.8K | $958.7K | 0.27% | +$135.9K |
| Pyxis Oncology, Inc.(PYXS) | 957,408 | 613,253 | -344,155 | $3.51M | $956.7K | 0.27% | -$2.56M |
| Fulcrum Therapeutics, Inc.(FULC) | 75,000 | 200,096 | +125,096 | $267.8K | $940.5K | 0.27% | +$672.7K |
| Cartesian Therapeutics, Inc.(RNAC) | 52,193 | 52,166 | -27 | $841.4K | $934.3K | 0.27% | +$92.9K |
| Traws Pharma, Inc.(TRAW) | 0 | 98,493 | +98,493 | $0 | $874.6K | 0.25% | +$874.6K |
| Aclaris Therapeutics, Inc.(ACRS) | 0 | 350,000 | +350,000 | $0 | $868.0K | 0.25% | +$868.0K |
| Vigil Neuroscience Inc | 0 | 500,000 | +500,000 | $0 | $850.0K | 0.24% | +$850.0K |
| Tyra Biosciences, Inc.(TYRA) | 0 | 60,000 | +60,000 | $0 | $834.0K | 0.24% | +$834.0K |
| Lyell Immunopharma, Inc.(LYEL) | 526,066 | 1,276,037 | +749,971 | $726.0K | $816.7K | 0.23% | +$90.7K |
| COMPASS Pathways plcADS(CMPS) | 202,908 | 202,894 | -14 | $1.28M | $766.9K | 0.22% | -$511.4K |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 274,551 | 201,187 | -73,364 | $889.5K | $760.5K | 0.22% | -$129.1K |
| Kezar Life Sciences Inc COM NEW | 0 | 106,901 | +106,901 | $0 | $718.4K | 0.21% | +$718.4K |
| Nurix Therapeutics, Inc.(NRIX) | 260,000 | 34,985 | -225,015 | $5.84M | $659.1K | 0.19% | -$5.18M |
| Tessera Defense and Homeland Security Inc.(HLSQ) | 893,000 | 892,976 | -24 | $910.9K | $652.0K | 0.19% | -$258.9K |
| Inhibrx Biosciences, Inc.(INBX) | 42,123 | 42,122 | -1 | $659.6K | $648.7K | 0.19% | -$11.0K |
| Aethlon Med Inc | 0 | 750,000 | +750,000 | $0 | $645.0K | 0.18% | +$645.0K |
| Veru Inc.(VERU) | 946,382 | 945,239 | -1,143 | $727.8K | $614.9K | 0.18% | -$112.9K |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 284,715 | 51,431 | -233,284 | $5.87M | $606.9K | 0.17% | -$5.27M |
| Iteos Therapeutics Inc | 78,574 | 78,585 | +11 | $802.2K | $603.5K | 0.17% | -$198.7K |
| Sana Biotechnology, Inc.(SANA) | 0 | 365,000 | +365,000 | $0 | $594.9K | 0.17% | +$594.9K |
| Olema Pharmaceuticals, Inc.(OLMA) | 92,000 | 91,994 | -6 | $1.10M | $536.3K | 0.15% | -$562.2K |
| Acumen Pharmaceuticals, Inc.(ABOS) | 266,435 | 265,769 | -666 | $660.8K | $457.1K | 0.13% | -$203.6K |
| Mind Medicine Mindmed Inc | 62,481 | 62,691 | +210 | $355.5K | $436.3K | 0.12% | +$80.8K |
| Spruce Biosciences Inc | 0 | 1,000,000 | +1,000,000 | $0 | $420.0K | 0.12% | +$420.0K |
| Travere Therapeutics, Inc.(TVTX) | 0 | 22,600 | +22,600 | $0 | $393.7K | 0.11% | +$393.7K |
| Elevation Oncology Inc | 690,089 | 690,050 | -39 | $414.0K | $388.2K | 0.11% | -$25.8K |
| Chemomab Therapeutics LtdADS | 213,392 | 213,052 | -340 | $335.0K | $385.6K | 0.11% | +$50.6K |
| Perspective Therapeutics, Inc.(CATX) | 0 | 108,300 | +108,300 | $0 | $345.5K | 0.10% | +$345.5K |
| Faeth Therapeutics, Inc.(FTH) | 650,000 | 649,963 | -37 | $388.7K | $318.5K | 0.09% | -$70.2K |
| Voyager Therapeutics, Inc.(VYGR) | 55,857 | 55,766 | -91 | $326.8K | $316.2K | 0.09% | -$10.6K |
| Climb Bio, Inc.(CLYM) | 175,100 | 175,088 | -12 | $891.3K | $315.2K | 0.09% | -$576.1K |
| Avenue Therapeutics Inc | 0 | 140,000 | +140,000 | $0 | $280.0K | 0.08% | +$280.0K |
| Karyopharm Therapeutics Inc.(KPTI) | 409,355 | 408,899 | -456 | $339.8K | $276.5K | 0.08% | -$63.2K |
| Anebulo Pharmaceuticals Inc | 157,862 | 157,720 | -142 | $304.7K | $265.0K | 0.08% | -$39.7K |
| MacroGenics, Inc.(MGNX) | 80,079 | 80,071 | -8 | $263.5K | $260.2K | 0.07% | -$3.2K |